Dr Martens warns over earnings after warm weather drags on sales
The company also said it has been affected by weakness in the US.
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Dr Martens has warned that earnings for the year are set to fall below expectations after it was knocked by weak US trading and warm weather.
On Thursday, the boot and shoe company revealed that sales slumped over the half-year to September as it continued to face pressure from waning demand, particularly in its US wholesale business where business customers have been cautious with orders.
Chief executive Kenny Wilson said: “We are undoubtedly facing some more challenging headwinds in the US, but we are continuing to invest in the business, we continue to have faith in our iconic brand, and we continue to believe in the long-term growth potential of the business.”
He said the US business is facing an “increasingly difficult consumer environment” and is therefore looking to “refocus” its marketing efforts in the region and improve online trading.
It was also knocked by warm weather at the start of the autumn/winter season, although trading in Europe, the Middle East and Asia Pacific has improved in recent weeks.
Dr Martens said it expects earnings to be “moderately below the bottom end of the range of consensus expectations”, while finance costs are also expected to affect profits.
It added that sales for the year are set fall by high single digits, compared with the previous year.
It came as the firm revealed that sales fell by 5% to £395.8 million in the six months to September 30, driven by the US sales slump.
Mr Wilson added: “We saw a mixed trading performance in the first half of the year.
“We made good progress with our strategic priorities, continuing to invest in the business and our people to drive sustainable long-term growth.
“During the period we focused on controlling the controllables: we delivered significant supply chain savings, successfully transformed our North America distribution network, opened 25 new stores, and launched a Dr Martens UK repair service.”